Clinical Trials Compliance Packaging Pharmaceutical 
Cannabis Law Report
FEBRUARY 5, 2022
Responsible for creation and maintenance of all regulatory documentation, including but not limited to, product packaging, labelling, inserts, working in conjunction with the marketing team for design, and assuring regulatory compliance across all territories. ROLE/RESPONSIBILITIES. Support export and import permitting and licensing.
Cannabis Law Report
DECEMBER 15, 2021
Responsible for creation and maintenance of all regulatory documentation, including but not limited to, product packaging, labelling, inserts, working in conjunction with the marketing team for design, and assuring regulatory compliance across all territories. ROLE/RESPONSIBILITIES. Support export and import permitting and licensing.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
OCTOBER 2, 2021
The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. We are pioneering a new kind of pharmaceutical company that prioritizes public benefit and is committed to sustainability, accountability, and transparency.
Cannabis Law Report
NOVEMBER 19, 2021
It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. Team leadership : mentor European study teams in overall regulatory strategy and compliance to enable future patient access expeditiously.
Cannabis Law Report
OCTOBER 10, 2021
As a senior manager at Cantourage and with us as a team you can develop and shape the pharmaceuticals market in Europe. Provide guidance on clinical trials and plays integral role in bringing new product innovations to different markets in Europe (and beyond). Customized compensation package.
Cannabis Law Report
NOVEMBER 19, 2021
It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. A minimum of 5-7 years of legal experience in healthcare or pharmaceutical-related fields. Deputy General Counsel Executive Summary.
Cannabis Law Report
SEPTEMBER 8, 2021
The Company provides proprietary cannabis processing services, in addition to best-in-class product development, manufacturing, and commercialization of cannabis consumer packaged goods. About Epsilon Healthcare Limited Epsilon Healthcare (ASX:EPN) is an ASX listed diversified global healthcare and pharmaceuticals company.
Expert insights. Personalized for you.
52 
Let's personalize your content